Italy says it has blocked a shipment to Australia of AstraZeneca’s COVID-19 vaccine in the first such export ban under an EU vaccine monitoring scheme.
Italy’s order blocking the dispatch of more than 250,000 doses was accepted by the European Commission, which has fiercely criticised the Anglo-Swedish company this year for supplying just a fraction of the vaccine doses it had promised to deliver to the bloc.
The shipment was stopped because of the “continuing shortage of vaccines in the EU and in Italy and delays in supplies from AstraZeneca to the EU and Italy,” the Italian foreign ministry said in a statement.
It was also blocked because Australia is not considered a “vulnerable” country in the context of the pandemic, and because of the “high number of doses” requested.
The ministry said AstraZeneca requested an export permit on 24 February, and Italy forwarded the request to the European Commission two days later, proposing its rejection.
The EU executive body agreed, and the Italian government – whose new Prime Minister Mario Draghi has pledged to ramp up national vaccination efforts – notified AstraZeneca of its decision on 2 March.
The ministry said Italy had previously authorised the export of AstraZeneca vaccine samples, but only in “modest quantities … for scientific research purposes.”
The doses came from a plant in Italy operated by AstraZeneca to produce some of its vaccine, one of three authorised for use in the EU alongside the BioNTech-Pfizer and Moderna versions.
Under the commission’s “transparency and authorisation mechanism” EU member states vet planned exports out of the bloc of authorised COVID-19 vaccines.
The scheme started on 30 January and is to run until at least the end of March.
That period corresponds to a sharp shortfall in the first three months of this year of deliveries the EU had been counting on to kickstart its vaccine roll-out.
Most the shortfall is because AstraZeneca has pledged “best reasonable efforts” to deliver around 100 million doses in that time, but is now on track to supply just 40 per cent of that.
At the same time, the UK-based company is fully supplying former EU member Britain with doses for its world-leading vaccination program.
Like this story? Here’s where else you can find SBS News content and follow us:
SBS News website: Save our website sbs.com.au/news as a favourite.
SBS News app: Download our app from Apple’s App Store or Google Play and subscribe to the alerts.
SBS News newsletters: Get the latest delivered to your email inbox by subscribing here.
Apple News: Follow the SBS News channel here on an Apple device.
Twitter: Follow us at twitter.com/SBSNews
Instagram: Follow us at instagram.com/sbsnews_au
YouTube: Subscribe at youtube.com/c/sbsnews
TikTok: Follow us at tiktok.com/@sbsnews_au
Reddit: Join us at reddit.com/r/sbsnewsau
SBS also publishes news in 68 languages online and on radio. Find your language at sbs.com.au/language.
You can also find stories from Dateline, Insight, The Feed and NITV on their websites and social media platforms.
